Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Anne Laure Sellier-Leclerc"'
Autor:
Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, David J. Sas, Mini Michael, Anne-Laure Sellier-Leclerc, Julien Hogan, Richard Willey, John M. Gansner, Daniella Magen
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
BackgroundPrimary hyperoxaluria type 1 (PH1) is a genetic disorder resulting in overproduction of hepatic oxalate, potentially leading to recurrent kidney stones, nephrocalcinosis, chronic kidney disease, and kidney failure. Lumasiran, the first RNA
Externí odkaz:
https://doaj.org/article/22831d3639fc447396b0f620921112a5
Autor:
Sally A. Hulton, Jaap W. Groothoff, Yaacov Frishberg, Michael J. Koren, J. Scott Overcash, Anne-Laure Sellier-Leclerc, Hadas Shasha-Lavsky, Jeffrey M. Saland, Wesley Hayes, Daniella Magen, Shabbir H. Moochhala, Martin Coenen, Eva Simkova, Sander F. Garrelfs, David J. Sas, Kristin A. Meliambro, Taylor Ngo, Marianne T. Sweetser, Bahru A. Habtemariam, John M. Gansner, Tracy L. McGregor, John C. Lieske
Publikováno v:
Kidney International Reports, Vol 7, Iss 3, Pp 494-506 (2022)
Introduction: Primary hyperoxaluria type 1 (PH1) is a rare genetic disease caused by hepatic overproduction of oxalate, leading to kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis. In the 6-month double-blind period (DBP) of ILL
Externí odkaz:
https://doaj.org/article/d1c32da830c840358e1a339f45ee8a45
Autor:
Elodie Cheyssac, Hamidou Savadogo, Nathan Lagoutte, Véronique Baudouin, Marina Charbit, Robert Novo, Anne-Laure Sellier-Leclerc, Marc Fila, Stéphane Decramer, Elodie Merieau, Ariane Zaloszyc, Jérôme Harambat, Gwenaelle Roussey
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2023)
IntroductionPrimary infection or reactivation of Epstein-Barr Virus (EBV) is a significant cause of morbidity and mortality in pediatric kidney transplantation. Valganciclovir (VGC) treatment is recommended for prophylaxis of cytomegalovirus infectio
Externí odkaz:
https://doaj.org/article/8166121861074e26ae5ff5ce788f395b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Djamal Djeddi, Julien Hogan, Aubriana Perez, Anne-Laure Sellier-Leclerc, Isabelle Vrillon, Francoise Broux, Francois Nobili, Jerome Harambat, Lucie Bessenay, V Audard, Camille Faudeux, Denis Morin, Christine Pietrement, Stephanie Tellier, Philippe Eckart, Annie Lahoche, G Roussey-Kesler, Tim Ulinski, Olivia Boyer, Emmanuelle Plaisier, Sylvie Cloarec, Anne Jolivot, Vincent Guigonis, Sophie Guilmin-Crepon, Veronique Baudouin, Claire Dossier, Georges Deschênes
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Introduction Guidelines for the treatment of steroid-dependent nephrotic syndrome (SDNS) and frequently relapsing nephrotic syndrome (FRNS) are lacking. Given the substantial impact of SDNS/FRNS on quality of life, strategies aiming to provide long-t
Externí odkaz:
https://doaj.org/article/76578aec60b04d49a318ba77bf7b3fdb
Autor:
Anne-Laure Sellier-Leclerc, Elisabeth Metry, Stéphanie Clave, Peggy Perrin, Cécile Acquaviva-Bourdain, Charlène Levi, Meindert Crop, Sophie Caillard, Bruno Moulin, Jaap Groothoff, Justine Bacchetta
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association-European Renal Association, 38(2), 517-521. Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e98dd556e606ba556b9c946a61b1dc
https://doi.org/10.1093/ndt/gfac295
https://doi.org/10.1093/ndt/gfac295
Autor:
null John Lieske, Jeffrey Saland, Jaap Groothoff, Yaacov Frishberg, Hadas Shasha-Lavsky, Daniella Magen, Shabbir Moochhala, Eva Simkova, Martin Coenen, Wesley Hayes, Julien Hogan, Anne-Laure Sellier-Leclerc, Yinggu Bao, John Gansner, Sally-Anne Hulton
Publikováno v:
Journal of Urology. 209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::655a41619c769f7433c1c1a7b5192087
https://doi.org/10.1097/ju.0000000000003225.01
https://doi.org/10.1097/ju.0000000000003225.01
Autor:
Aurélie Hummel, Julie Oniszczuk, Delphine Kervella, Marina Charbit, Dominique Guerrot, Angelo Testa, Carole Philipponnet, Cécile Chauvet, Thomas Guincestre, Karine Brochard, Ariane Benezech, Lucile Figueres, Xavier Belenfant, Andrea Guarnieri, Nathalie Demoulin, Elisa Benetti, Marius Miglinas, Kathleen Dessaix, Johann Morelle, Andrea Angeletti, Anne-Laure Sellier-Leclerc, Bruno Ranchin, Guillaume Goussard, Laurent Hudier, Justine Bacchetta, Aude Servais, Vincent Audard
Publikováno v:
Clinical kidney journal, Vol. 15, no.8, p. 1574-1582 (2022)
Clinical kidney journal, Oxford : Oxford University Press, 2022, vol. 15, iss. 8, p. 1574-1582
Clinical kidney journal, Oxford : Oxford University Press, 2022, vol. 15, iss. 8, p. 1574-1582
Background Several cases of idiopathic nephrotic syndrome (INS) relapse following the administration of coronavirus disease 2019 (COVID-19) vaccines have recently been reported, raising questions about the potential relationship between the immune re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e18c3fc55d235d9dc495c0701cb29a
https://doi.org/10.1093/ckj/sfac134
https://doi.org/10.1093/ckj/sfac134
Autor:
David J. Sas, Daniella Magen, Wesley Hayes, Hadas Shasha-Lavsky, Mini Michael, Indra Schulte, Anne-Laure Sellier-Leclerc, Jiandong Lu, Ali Seddighzadeh, Bahru Habtemariam, Tracy L. McGregor, Kenji P. Fujita, Yaacov Frishberg, Justine Bacchetta, Véronique Baudouin, Rachel Becker-Cohen, Shimrit Tzvi Behr, Efrat Ben-Shalom, Maria Berdaguer, Detlef Bockenhauer, Pierre Cochat, Martin Coenen, Carl H. Cramer, Georges Deschênes, Claire Dossier, Emilie Doye, Liat Feraru Feldman, Maximilian Hohenadel, Florentia Kaguelidou, Irina Libinson Zebegret, John C. Lieske, Anne Maisin, Dawn S. Milliner, Moran Plonsky Toder, Shirley Pollack, Aurélie Portefaix, Bruno Ranchin, Choni Rinat, Adnan Safdar, Gesa Schalk, Poyyapakkam R. Srivaths, Cheryl L. Tran, William Van't Hoff, Jenny Weinbrand-Goichberg, Irith Weissman
Publikováno v:
Genetics in Medicine. 24:654-662
Primary hyperoxaluria type 1 (PH1) is a rare, progressive, genetic disease with limited treatment options. We report the efficacy and safety of lumasiran, an RNA interference therapeutic, in infants and young children with PH1.This single-arm, open-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444e63133cb10e1673648814d6fb0dc6
https://doi.org/10.1016/j.gim.2021.10.024
https://doi.org/10.1016/j.gim.2021.10.024
Autor:
Marie-Noëlle, Méaux, Anne-Laure, Sellier-Leclerc, Cécile, Acquaviva-Bourdain, Jérôme, Harambat, Lise, Allard, Justine, Bacchetta
Publikováno v:
Pediatric Nephrology. 37:907-911
Lumasiran, a sub-cutaneous RNA-interference therapy, has been recently approved for primary hyperoxaluria type 1 (PH1), with doses and intervals according to body weight. Little is known as to its use in infants; the aim of this study was to describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f418b5af53c8b6fa7c995446e0f04d
https://doi.org/10.1007/s00467-021-05393-1
https://doi.org/10.1007/s00467-021-05393-1